Alafair Biosciences

About:

Alafair Biosciences specializes in commercializing biomaterials and biomedical devices that enhance internal wound healing.

Website: http://alafairbiosciences.com

Twitter/X: alafairbio

Top Investors: ATP Fund, TEXO Ventures, UT Horizon Fund, Texas Venture Labs

Description:

Alafair Biosciences develops cross-linked polysaccharide hydrogel films for the post-surgical complication of adhesion or tethering between opposing tissue surfaces. It focuses on the development of membranes, bilayers, and injectable gel solutions for anti-adhesion, wound care, and tissue reconstruction applications. The company was founded in 2011 and is based in Austin, Texas.

Total Funding Amount:

$13.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)alafairbiosciences.com

Founders:

Ben Walthall, Daniel L. Peterson, John D. Joyoprayitno, Sarah Mayes

Number of Employees:

11-50

Last Funding Date:

2019-04-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai